Treating and preventing acute exacerbations of COPD
Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health. Corticosteroids, antibiotics, and bronchod...
Gespeichert in:
| Veröffentlicht in: | Cleveland Clinic journal of medicine 2016-04, Vol.83 (4), p.289-300 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 300 |
|---|---|
| container_issue | 4 |
| container_start_page | 289 |
| container_title | Cleveland Clinic journal of medicine |
| container_volume | 83 |
| creator | Hatipoglu, Umur S Aboussouan, Loutfi S |
| description | Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health. Corticosteroids, antibiotics, and bronchodilators are the cornerstones of prevention and therapy, with mucolytics, oxygen supplementation, and ventilatory support also advisable for some patients. Treatment should be evidence-based and tailored to the patient's history and present needs. |
| doi_str_mv | 10.3949/ccjm.83a.14188 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1779887396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1779887396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335t-24ffdcd1127cb9a7fc7dedb92d0a274faf60bef744a960f66b6e98ec2b9cc1353</originalsourceid><addsrcrecordid>eNo9kDtPwzAUhS0EoqWwMqKMLAl-JLbviMpTqlSGMlu2c41aNUmxEwT_npQC09GRvnOGj5BLRgsBJdx4v2kKLWzBSqb1EZkyEJBzLeGYTKkGljNW0Qk5S2lDKa8Yh1My4YpWFadiSsQqou3X7Vtm2zrbRfzA9lD90GOGn9ZjdCPRtSnrQjZfvtydk5NgtwkvfnNGXh_uV_OnfLF8fJ7fLnIvRNXnvAyh9jVjXHkHVgWvaqwd8Jparspgg6QOgypLC5IGKZ1E0Oi5A--ZqMSMXB9-d7F7HzD1plknj9utbbEbkmFKgdZKgBzR4oD62KUUMZhdXDc2fhlGzV6U2YsyoyjzI2ocXP1-D67B-h__MyO-AfJBZLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779887396</pqid></control><display><type>article</type><title>Treating and preventing acute exacerbations of COPD</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hatipoglu, Umur S ; Aboussouan, Loutfi S</creator><creatorcontrib>Hatipoglu, Umur S ; Aboussouan, Loutfi S</creatorcontrib><description>Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health. Corticosteroids, antibiotics, and bronchodilators are the cornerstones of prevention and therapy, with mucolytics, oxygen supplementation, and ventilatory support also advisable for some patients. Treatment should be evidence-based and tailored to the patient's history and present needs.</description><identifier>ISSN: 0891-1150</identifier><identifier>EISSN: 1939-2869</identifier><identifier>DOI: 10.3949/ccjm.83a.14188</identifier><identifier>PMID: 27055203</identifier><language>eng</language><publisher>United States</publisher><subject>Acidosis, Respiratory - etiology ; Acidosis, Respiratory - therapy ; Acute Disease - therapy ; Administration, Inhalation ; Albuterol - administration & dosage ; Anti-Bacterial Agents - therapeutic use ; Bronchodilator Agents - administration & dosage ; Disease Progression ; Glucocorticoids - administration & dosage ; Humans ; Prednisone - administration & dosage ; Pulmonary Disease, Chronic Obstructive - complications ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Pulmonary Disease, Chronic Obstructive - pathology ; Respiration, Artificial - methods ; Risk Factors</subject><ispartof>Cleveland Clinic journal of medicine, 2016-04, Vol.83 (4), p.289-300</ispartof><rights>Copyright © 2016 Cleveland Clinic.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c335t-24ffdcd1127cb9a7fc7dedb92d0a274faf60bef744a960f66b6e98ec2b9cc1353</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27055203$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hatipoglu, Umur S</creatorcontrib><creatorcontrib>Aboussouan, Loutfi S</creatorcontrib><title>Treating and preventing acute exacerbations of COPD</title><title>Cleveland Clinic journal of medicine</title><addtitle>Cleve Clin J Med</addtitle><description>Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health. Corticosteroids, antibiotics, and bronchodilators are the cornerstones of prevention and therapy, with mucolytics, oxygen supplementation, and ventilatory support also advisable for some patients. Treatment should be evidence-based and tailored to the patient's history and present needs.</description><subject>Acidosis, Respiratory - etiology</subject><subject>Acidosis, Respiratory - therapy</subject><subject>Acute Disease - therapy</subject><subject>Administration, Inhalation</subject><subject>Albuterol - administration & dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bronchodilator Agents - administration & dosage</subject><subject>Disease Progression</subject><subject>Glucocorticoids - administration & dosage</subject><subject>Humans</subject><subject>Prednisone - administration & dosage</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Pulmonary Disease, Chronic Obstructive - pathology</subject><subject>Respiration, Artificial - methods</subject><subject>Risk Factors</subject><issn>0891-1150</issn><issn>1939-2869</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAUhS0EoqWwMqKMLAl-JLbviMpTqlSGMlu2c41aNUmxEwT_npQC09GRvnOGj5BLRgsBJdx4v2kKLWzBSqb1EZkyEJBzLeGYTKkGljNW0Qk5S2lDKa8Yh1My4YpWFadiSsQqou3X7Vtm2zrbRfzA9lD90GOGn9ZjdCPRtSnrQjZfvtydk5NgtwkvfnNGXh_uV_OnfLF8fJ7fLnIvRNXnvAyh9jVjXHkHVgWvaqwd8Jparspgg6QOgypLC5IGKZ1E0Oi5A--ZqMSMXB9-d7F7HzD1plknj9utbbEbkmFKgdZKgBzR4oD62KUUMZhdXDc2fhlGzV6U2YsyoyjzI2ocXP1-D67B-h__MyO-AfJBZLg</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Hatipoglu, Umur S</creator><creator>Aboussouan, Loutfi S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160401</creationdate><title>Treating and preventing acute exacerbations of COPD</title><author>Hatipoglu, Umur S ; Aboussouan, Loutfi S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335t-24ffdcd1127cb9a7fc7dedb92d0a274faf60bef744a960f66b6e98ec2b9cc1353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acidosis, Respiratory - etiology</topic><topic>Acidosis, Respiratory - therapy</topic><topic>Acute Disease - therapy</topic><topic>Administration, Inhalation</topic><topic>Albuterol - administration & dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bronchodilator Agents - administration & dosage</topic><topic>Disease Progression</topic><topic>Glucocorticoids - administration & dosage</topic><topic>Humans</topic><topic>Prednisone - administration & dosage</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Pulmonary Disease, Chronic Obstructive - pathology</topic><topic>Respiration, Artificial - methods</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hatipoglu, Umur S</creatorcontrib><creatorcontrib>Aboussouan, Loutfi S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cleveland Clinic journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hatipoglu, Umur S</au><au>Aboussouan, Loutfi S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treating and preventing acute exacerbations of COPD</atitle><jtitle>Cleveland Clinic journal of medicine</jtitle><addtitle>Cleve Clin J Med</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>83</volume><issue>4</issue><spage>289</spage><epage>300</epage><pages>289-300</pages><issn>0891-1150</issn><eissn>1939-2869</eissn><abstract>Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health. Corticosteroids, antibiotics, and bronchodilators are the cornerstones of prevention and therapy, with mucolytics, oxygen supplementation, and ventilatory support also advisable for some patients. Treatment should be evidence-based and tailored to the patient's history and present needs.</abstract><cop>United States</cop><pmid>27055203</pmid><doi>10.3949/ccjm.83a.14188</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0891-1150 |
| ispartof | Cleveland Clinic journal of medicine, 2016-04, Vol.83 (4), p.289-300 |
| issn | 0891-1150 1939-2869 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1779887396 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Acidosis, Respiratory - etiology Acidosis, Respiratory - therapy Acute Disease - therapy Administration, Inhalation Albuterol - administration & dosage Anti-Bacterial Agents - therapeutic use Bronchodilator Agents - administration & dosage Disease Progression Glucocorticoids - administration & dosage Humans Prednisone - administration & dosage Pulmonary Disease, Chronic Obstructive - complications Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - pathology Respiration, Artificial - methods Risk Factors |
| title | Treating and preventing acute exacerbations of COPD |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A43%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treating%20and%20preventing%20acute%20exacerbations%20of%20COPD&rft.jtitle=Cleveland%20Clinic%20journal%20of%20medicine&rft.au=Hatipoglu,%20Umur%20S&rft.date=2016-04-01&rft.volume=83&rft.issue=4&rft.spage=289&rft.epage=300&rft.pages=289-300&rft.issn=0891-1150&rft.eissn=1939-2869&rft_id=info:doi/10.3949/ccjm.83a.14188&rft_dat=%3Cproquest_cross%3E1779887396%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1779887396&rft_id=info:pmid/27055203&rfr_iscdi=true |